Page last updated: 2024-10-25

desipramine and Hyperprolactinemia

desipramine has been researched along with Hyperprolactinemia in 1 studies

Desipramine: A tricyclic dibenzazepine compound that potentiates neurotransmission. Desipramine selectively blocks reuptake of norepinephrine from the neural synapse, and also appears to impair serotonin transport. This compound also possesses minor anticholinergic activity, through its affinity to muscarinic receptors.
desipramine : A dibenzoazepine consisting of 10,11-dihydro-5H-dibenzo[b,f]azepine substituted on nitrogen with a 3-(methylamino)propyl group.

Hyperprolactinemia: Increased levels of PROLACTIN in the BLOOD, which may be associated with AMENORRHEA and GALACTORRHEA. Relatively common etiologies include PROLACTINOMA, medication effect, KIDNEY FAILURE, granulomatous diseases of the PITUITARY GLAND, and disorders which interfere with the hypothalamic inhibition of prolactin release. Ectopic (non-pituitary) production of prolactin may also occur. (From Joynt, Clinical Neurology, 1992, Ch36, pp77-8)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Teoh, SK1
Mendelson, JH1
Mello, NK1
Weiss, R1
McElroy, S1
McAfee, B1

Trials

1 trial available for desipramine and Hyperprolactinemia

ArticleYear
Hyperprolactinemia and risk for relapse of cocaine abuse.
    Biological psychiatry, 1990, Nov-01, Volume: 28, Issue:9

    Topics: Adult; Cocaine; Desipramine; Double-Blind Method; Female; Humans; Hyperprolactinemia; Male; Prolacti

1990